SCHEMBL3392210

SCHEMBL3392210

FC(F)(F)Oc1ccc(CNCCc2ccc(-c3ccc(Br)cc3)o2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRMT1 Q99873 2/20 0.47
RXFP1 Q9HBX9 4/20 0.41
MAPT P10636 2/20 0.41
ALDH1A1 P00352 1/20 0.41
PKM P14618 1/20 0.41
HPGD P15428 1/20 0.41
TSHR P16473 1/20 0.41
PPARG P37231 1/20 0.41
NCOA2 Q15596 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
HSD17B10 Q99714 1/20 0.41
NCOR2 Q9Y618 1/20 0.41
SCN8A Q9UQD0 1/20 0.41
SCN10A Q9Y5Y9 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.38
HTR2A P28223 6/20 0.38
HTR6 P50406 6/20 0.38
DRD2 P14416 4/20 0.38
HTR7 P34969 4/20 0.38
HTR1A P08908 3/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3392207 0.76 PRMT1 (0.62) PRMT1RXFP1MAPTALDH1A1PKM
SCHEMBL13680868 0.73 PRMT1 (0.49) PRMT1RXFP1MAPTALDH1A1PKM
SCHEMBL22042121 0.70 PRMT1 (0.54) PRMT1MAPTALDH1A1PKMHPGD
SCHEMBL3392203 0.70 SCN8A (0.40) SCN8AHTR2ACHEK1CA12CA1
SCHEMBL8348550 0.69 SCN8A (0.55) MAPTALDH1A1TSHRSCN8ALMNA
SCHEMBL4575327 0.68 BCHE (0.59) SCN8AL3MBTL1CA1CA2
Hydrochloric Acid SCHEMBL6122751 0.68 SCN8A (0.54) MAPTALDH1A1TSHRSCN8ALMNA
SCHEMBL4150750 0.68 KIF11 (0.49) MAPTALDH1A1SCN8ASCN10ACA12
SCHEMBL19243611 0.67 SCN8A (0.55) MAPTALDH1A1TSHRSCN8ASMN1; SMN2
SCHEMBL9903315 0.67 SCN8A (0.58) MAPTSCN8ASMN1; SMN2CA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2246329-A1 4(1H)-pyridinone derivatives and their use as antimalaria agents Glaxo Group Limited (GB) 2010-11-03 EP disclosed